Friday May 17 | BayStreet.ca
StockCall Scrutinizes STJ, HOLX, NAVB, EW, and RMD
StockCall.com Provides Stock Research on St. Jude Medical Inc., Hologic Inc., Navidea Biopharmaceuticals Inc., Edwards Lifesciences Corp., and ResMed Inc.
Navidea Biopharmaceuticals, Inc Management Discusses Q1 2013 Results - Earnings Call Transcript
Greetings and welcome to the Navidea Biopharmaceuticals First Quarter 2013 Earnings Call.
Navidea loses $7M in last zero-revenue quarter before Lymphoseek sales
Navidea Biopharmaceuticals Inc. on Wednesday reported it lost $7 million in the first quarter, the final zero-revenue quarter for the company leading up to sales that started this month of its first FDA-approved drug.
Navidea Biopharmaceuticals (NAVB) Releases Quarterly Earnings, Beats Expectations By $0.01 EPS
Navidea Biopharmaceuticals announced its earnings results on Wednesday. The company reported EPS for the quarter, beating the Thomson Reuters consensus estimate of by $0.01, Stock Ratings Network.com reports.
Navidea Biopharmaceuticals to Announce First Quarter 2013 Financial...
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals to Announce First Quarter 2013 Financial...
Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the first quarter of 2013, on Wednesday, May 8, 2013 before the market opens.
Navidea Biopharmaceuticals, Inc - Special Call
Greetings. Welcome to the Navidea Biopharmaceuticals Lymphoseek Launch Call. [Operator Instructions] As a reminder, this conference is being recorded.
At long last, Lymphoseek launch marks milestone for Navidea
Thirty years after it was founded and a dozen since it licensed a radioactive cancer-detection aid, Navidea Biopharmaceuticals Inc.
Navidea Biopharmaceuticals to Present at the 12th Annual Healthcare Conference
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals Announces Underwritten Sale of Common Stock
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! DUBLIN, Ohio-- --Navidea Biopharmaceuticals, Inc.